Racial Disparity in Bladder Cancer: Trends in Tumor Presentation at Diagnosis

Journal of Urology

Volumn 176, Issue 3, 2006, Pages 927-934

  Lee, Cheryl T ^a   Dunn, Rodney L ^a   Williams, Candice ^a   Underwood III, Willie ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

bladder; bladder neoplasms; continental population groups

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; SAMPLE SIZE; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; URINARY BLADDER NEOPLASMS;

EID: 33746486938     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.04.074     Document Type: Article

References (20)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10
2. Bach P.B., Schrag D., Brawley O.W., Galaznik A., Yakren S., and Begg C.B. Survival of blacks and whites after a cancer diagnosis. JAMA 287 (2002) 2106
3. Hankey B.F., and Myers M.H. Black/white differences in bladder cancer patient survival. J Chronic Dis 40 (1987) 65
4. Prout Jr. G.R., Wesley M.N., Greenberg R.S., Chen V.W., Brown C.C., Miller A.W., et al. Bladder cancer. race differences in extent of disease at diagnosis. Cancer 89 (2000) 1349
5. Mayer W.J., and McWhorter W.P. Black/white differences in non-treatment of bladder cancer patients and implications for survival. Am J Public Health 79 (1989) 772
6. Prout Jr. G.R., Wesley M.N., McCarron P.G., Chen V.W., Greenberg R.S., Mayberry R.M., et al. Survival experience of black patients and white patients with bladder carcinoma. Cancer 100 (2004) 621
7. Stein J.P., Lieskovsky G., Cote R., Groshen S., Feng A.C., Boyd S., et al. Radical cystectomy in the treatment of invasive bladder cancer. long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
8. Schultz P.K., Herr H.W., Zhang Z.F., Bajorin D.F., Seidman A., Sarkis A., et al. Neoadjuvant chemotherapy for invasive bladder cancer. prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J Clin Oncol 12 (1994) 1394
9. Van Der Meijden A., Sylvester R., Collette L., Bono A., and Ten Kate F. The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors. a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials. J Urol 164 (2000) 1533
10. Lin C.C., Rogot E., Johnson N.J., Sorlie P.D., and Arias E. A further study of life expectancy by socioeconomic factors in the National Longitudinal Mortality Study. Ethn Dis 13 (2003) 240
11. Gore J.L., Kwan L., Saigal C.S., and Litwin M.S. Marriage and mortality in bladder carcinoma. Cancer 104 (2005) 1188
12. Gu J., Liang D., Wang Y., Lu C., and Wu X. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutation Res 581 (2005) 97
13. Yu M.C., Ross R.K., Chan K.K., Henderson B.E., Skipper P.L., Tannenbaum S.R., et al. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 4 (1995) 861
14. Fowler Jr. F.J., McNaughton Collins M., Albertsen P.C., Zietman A., Elliott D.B., and Barry M.J. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 283 (2000) 3217
15. Underwood W., De Monner S., Ubel P., Fagerlin A., Sanda M.G., and Wei J.T. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 171 (2004) 1504
16. Shavers V.L., Harlan L.C., and Stevens J.L. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97 (2003) 134
17. Konety B.R., and Joslyn S.A. Factors influencing aggressive therapy for bladder cancer. an analysis of data from the SEER program. J Urol 170 (2003) 1765
18. Snyder C., Harlan L., Knopf K., Potosky A., and Kaplan R. Patterns of care for the treatment of bladder cancer. J Urol 169 (2003) 1697
19. Miller D.C., Taub D.A., Dunn R.L., Montie J.E., and Wei J.T. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 169 (2003) 105
20. Mensah G.A., Mokdad A.H., Ford E.S., Greenlund K.J., and Croft J.B. State of disparities in cardiovascular health in the United States. Circulation 111 (2005) 1233